President and Chief Executive Officer, Acetylon Pharmaceuticals. Mr. Ogier's industry experience spans development of small molecule drugs, monoclonal antibodies, growth factors, adult stem cell and immune cell therapies, gene therapies, bone marrow and solid organ transplantation, therapeutic medical devices and blood diagnostics
inflammatory/ autoimmune diseases and genetic blood disorders. Mr. Ogier has been involved with Malaria Free World since its founding and has inspired many of Malaria Free World's programs and events.
Assistant Professor Harvard Medical School, Co-Director of the Chemical Biology Platform at the Center for Systems Biology, Member of the Infectious Diseases Initiative at the Broad Institute, and an Assistant Professor in the Department of Immunology and Infectious Diseases Harvard School of Public Health. Dr. Mazitschek has been an adviser of Malaria Free World since its founding and will be the keynote speaker at Malaria Meltdown.
Chief Executive Officer and Co-Founder, bublup. Chief Executive Officer and Co-Founder, Cobro Ventures. Chairman and Co-Founder, Acetylon Pharmaceuticals. Chairman and Co-Founder, OncoPep. Co-Founder and Former Chairman and Chief Executive Officer, OPNET. One of Kritika Singh's lifelong mentors and been involved with Malaria Free World since its founding. Guided Ms. Singh to work on malaria research and inspired her to take it further.
VP Chemistry and Manufacturing, Acetylon Pharmaceuticals. Dr. van Duzer is the author of numerous peer-reviewed publications and an author of over 30 issued US drug patents. He is the project lead of The Malaria Initiative at Acetylon Pharmaceuticals. Dr. van Duzer was Kritika Singh's first boss and he got involved with Malaria Free World soon after its founding.
The Malaria Free World Advisory Board is comprised of leading malaria experts from academic as well as corporate institutions.